TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,075,320 | -41.3% | 9,817,622 | +74.4% | 0.01% | -28.6% |
| Q2 2023 | $139,804,140 | +21.6% | 5,628,186 | -26.4% | 0.01% | +16.7% |
| Q1 2023 | $114,961,886 | -53.3% | 7,643,805 | -63.3% | 0.01% | -14.3% |
| Q4 2022 | $246,422,710 | +254.2% | 20,830,322 | +77.3% | 0.01% | +75.0% |
| Q3 2022 | $69,562,000 | +15.0% | 11,750,400 | -17.5% | 0.00% | 0.0% |
| Q2 2022 | $60,500,000 | -33.9% | 14,235,263 | +47.8% | 0.00% | -20.0% |
| Q1 2022 | $91,568,000 | -17.3% | 9,628,584 | +65.3% | 0.01% | 0.0% |
| Q4 2021 | $110,659,000 | -22.6% | 5,824,178 | +35.5% | 0.01% | -37.5% |
| Q3 2021 | $142,996,000 | +2.1% | 4,296,752 | +19.0% | 0.01% | +14.3% |
| Q2 2021 | $140,115,000 | -10.8% | 3,612,147 | +10.8% | 0.01% | -22.2% |
| Q1 2021 | $157,097,000 | -18.7% | 3,259,281 | -12.2% | 0.01% | -25.0% |
| Q4 2020 | $193,142,000 | +75.6% | 3,712,842 | -9.6% | 0.01% | +50.0% |
| Q3 2020 | $109,960,000 | +12.3% | 4,109,119 | -18.3% | 0.01% | +14.3% |
| Q2 2020 | $97,928,000 | +184.8% | 5,027,127 | +43.9% | 0.01% | +133.3% |
| Q1 2020 | $34,387,000 | -9.0% | 3,494,653 | +2.6% | 0.00% | 0.0% |
| Q4 2019 | $37,799,000 | +72.1% | 3,405,305 | -12.9% | 0.00% | +50.0% |
| Q3 2019 | $21,959,000 | -51.5% | 3,910,724 | -25.2% | 0.00% | -33.3% |
| Q2 2019 | $45,239,000 | +71.7% | 5,229,981 | +59.6% | 0.00% | +50.0% |
| Q1 2019 | $26,347,000 | +48.0% | 3,276,966 | -24.5% | 0.00% | 0.0% |
| Q4 2018 | $17,805,000 | -23.1% | 4,342,618 | +5.0% | 0.00% | 0.0% |
| Q3 2018 | $23,161,000 | -52.5% | 4,135,717 | +11.4% | 0.00% | -50.0% |
| Q2 2018 | $48,811,000 | +10.2% | 3,712,103 | +19.0% | 0.00% | 0.0% |
| Q1 2018 | $44,278,000 | +58.3% | 3,118,261 | -8.6% | 0.00% | +100.0% |
| Q4 2017 | $27,975,000 | -27.4% | 3,411,666 | +4.9% | 0.00% | -33.3% |
| Q3 2017 | $38,542,000 | +45.4% | 3,252,465 | +23.3% | 0.00% | +50.0% |
| Q2 2017 | $26,515,000 | +223.0% | 2,638,683 | +274.4% | 0.00% | +100.0% |
| Q1 2017 | $8,209,000 | +160.0% | 704,787 | +3.8% | 0.00% | – |
| Q4 2016 | $3,157,000 | -35.9% | 679,115 | +6.7% | 0.00% | – |
| Q3 2016 | $4,925,000 | +30.2% | 636,355 | +1.9% | 0.00% | – |
| Q2 2016 | $3,783,000 | -62.4% | 624,307 | -47.1% | 0.00% | -100.0% |
| Q1 2016 | $10,064,000 | -26.1% | 1,181,038 | +3.4% | 0.00% | 0.0% |
| Q4 2015 | $13,624,000 | -48.7% | 1,141,921 | -56.7% | 0.00% | -66.7% |
| Q3 2015 | $26,560,000 | -23.5% | 2,635,023 | +25.9% | 0.00% | -25.0% |
| Q2 2015 | $34,711,000 | +34.4% | 2,092,249 | +25.5% | 0.00% | +33.3% |
| Q1 2015 | $25,820,000 | +357.9% | 1,667,684 | +368.6% | 0.00% | +200.0% |
| Q4 2014 | $5,639,000 | +94.7% | 355,916 | +31.1% | 0.00% | – |
| Q3 2014 | $2,896,000 | +38.6% | 271,392 | +21.9% | 0.00% | – |
| Q2 2014 | $2,089,000 | +45.0% | 222,643 | +6.5% | 0.00% | – |
| Q1 2014 | $1,441,000 | +158.2% | 208,987 | +46.6% | 0.00% | – |
| Q4 2013 | $558,000 | -29.6% | 142,554 | -8.5% | 0.00% | – |
| Q3 2013 | $793,000 | +113.7% | 155,764 | +168.9% | 0.00% | – |
| Q2 2013 | $371,000 | – | 57,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |